公众号 / 文章重症综合管理与镇静镇痛消化、代谢与肾脏急症

体外膜氧合串联连续肾脏替代治疗压力控制装置的设计与应用

[Design and application of a pressure control device for the continuous renal replacement therapy integrated in-series with extracorporeal membrane oxygenation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论一种新型压力调节夹可实时调节CRRT管路截面积以稳定引血与回血压力,减少压力相关报警并延长滤器寿命。

需要体外膜氧合(ECMO)的患者常需同时进行连续肾脏替代治疗(CRRT),串联整合是最常见的连接方式,但ECMO血流量和导管类型等因素常导致管路压力超过设备报警阈值。过大的负压或正压会影响CRRT回路引血和回血,导致频繁报警、治疗中断、滤器堵塞及血栓风险增加。东南大学附属中大医院重症护理团队研发了一种新型CRRT血管通路压力调节夹,已获中国国家实用新型专利(专利号:ZL 2021 2 1496610.7)。该装置通过锁定机制和锯齿条精确调节压迫距离以改变管路截面积,实时调节血流量并稳定引血和回血部位压力,可能提高ECMO期间CRRT的安全性和效率。

要点

  • ECMO串联CRRT时,ECMO血流量和导管类型等因素常使管路压力超过设备报警阈值,导致频繁报警、治疗中断和滤器堵塞。
  • 该压力调节夹由左右夹臂经顶部柔性塑料桥连接,内部双压缩面适配不同管径CRRT管路,底部锁定机制和锯齿条可精确调节压迫距离。
  • 装置通过调节管路截面积实时调控血流量,稳定CRRT回路引血和回血部位压力,减少压力相关报警并延长滤器寿命。
  • 该装置已获中国国家实用新型专利(专利号:ZL 2021 2 1496610.7),使用方便、成本效益好,适合广泛临床实施。

适用人群与场景

  • 需要体外膜氧合(ECMO)并同时需要连续肾脏替代治疗(CRRT)的患者。

处置流程与药物剂量

  • 将压力调节夹用于ECMO患者CRRT血管通路,通过底部锁定机制和锯齿条精确调节压迫距离,改变CRRT管路截面积,实时调节血流量并稳定引血和回血部位压力。

研究设计与关键结果

  • 该装置由东南大学附属中大医院重症护理团队研发,已获中国国家实用新型专利(专利号:ZL 2021 2 1496610.7)。
  • 装置由左右夹臂经顶部柔性塑料桥连接,内部双压缩面适配不同管径CRRT管路,底部锁定机制和锯齿条可精确调节压迫距离。

证据类型、等级与局限

  • 证据类型:装置设计与应用描述(非临床研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该装置可能减少ECMO串联CRRT期间压力相关报警、延长滤器寿命,从而提高CRRT实施的安全性和效率。
  • 该装置使用方便、成本效益好,适合广泛临床实施,可能减轻患者及家庭的整体治疗负担。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Patients requiring extracorporeal membrane oxygenation (ECMO) often need concurrent continuous renal replacement therapy (CRRT). At present, there are various connection methods between ECMO and CRRT circuits, among which in-series integration is the most common. However, ECMO blood flow and catheter type, pressure changes at the pre-pump, post-pump pre-oxygenator, and post-oxygenator segments frequently result in circuit pressures that exceed the alarm threshold of the device. Excessive negative or positive pressures may compromise blood withdrawal and return within the CRRT circuit, leading to frequent system alarms, interruptions in therapy, filter occlusion, and an increased risk of thrombus formation. To address this issue, the critical care nursing team of Zhongda Hospital Affiliated to Southeast University, developed a novel pressure-regulating clamp for CRRT vascular access in ECMO patient, which has been granted a National Utility Model Patent of China (patent number: ZL 2021 2 1496610.7). The device comprises opposing left and right clamp arms joined at the top by a flexible plastic bridge, with dual internal compression surfaces designed to fit CRRT tubing of various calibers. A locking mechanism and serrated strip at the base enable precise adjustment of the compression distance, thereby modulating the tubing's cross-sectional area. This configuration allows real-time regulation of blood flow and stabilization of pressures at blood withdrawal and return sites within the CRRT circuit. By reducing pressure-related alarms and extending filter life, the device may enhance the safety and efficiency of CRRT delivery during ECMO. It is user-friendly, cost-effective, and well-suited for broad clinical implementation, with the potential to alleviate the overall treatment burden on patients and their families.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Pu L, Li X, Ma L, et al. [Design and application of a pressure control device for the continuous renal replacement therapy integrated in-series with extracorporeal membrane oxygenation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41146551. doi:10.3760/cma.j.cn121430-20250427-00401

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。